Pharmaceutical Technology

In sterile pharmaceutical manufacturing, sterilization is no longer simply a final support step. It is a critical process that directly affects patient safety, regulatory compliance, product quality, and production efficiency.

The pharmaceutical industry is entering a new era of innovation, where digitalization, sustainability, automation, and regulatory excellence are transforming the way medicines are developed and manufactured.

From integrated weight control with automatic rejection to data matrix code printing and manual aggregation management, this technology is designed to ensure maximum compliance and security at every stage of packaging.

Pioneer Co. for Pharmaceutical Industries, one of the largest blow-fill-seal (BFS) manufacturers in the Middle East, has significantly strengthened its quality assurance processes by implementing advanced HEUFT spotter II BFS inspection systems.

In today’s high-precision manufacturing environment, ensuring product quality and safety is critical. Wilco’s advanced vision inspection systems, exclusively represented by Melchers Vietnam.

EU GMP Annex 1, issued by the European Medicines Agency (EMA), regulates the manufacture of sterile medicinal products. The latest revision (2022) became mandatory on 25 August 2023.

Thailand is accelerating its transformation into a regional biotechnology hub with the development of a GMP Biorefinery Pilot Plant at the Eastern Economic Corridor of Innovation (EECi).

Join us at Rommelag BFS Pharma Connect 2026, taking place April 22–23, 2026 in Gaildorf, Germany.

On December 3, 2025, Melchers Vietnam proudly hosted the Next-Gen Pharma Technology Symposium in Ho Chi Minh City.

In the highly regulated landscape of the pharmaceutical, biotechnology, and medical device industries, quality is not an option but a categorical imperative.